Investor notice: fate therapeutics, inc. investors with substantial losses have opportunity to lead the fate therapeutics class action lawsuit – fate

San diego--( business wire )--the law firm of robbins geller rudman & dowd llp announces that purchasers or acquirers of fate therapeutics, inc. (nasdaq: fate) securities between april 2, 2020 and january 5, 2023, inclusive (the “class period”) have until march 22, 2023 to seek appointment as lead plaintiff in the fate therapeutics class action lawsuit. captioned hadian v. fate therapeutics, inc., no. 23-cv-00111 (s.d. cal.), the fate therapeutics class action lawsuit charges fate therapeutics and certain of its top executives with violations of the securities exchange act of 1934.
FATE Ratings Summary
FATE Quant Ranking